Skip to content

Study · Measured the body's own peptide · 2022

1 result

Plasma proteome profiling using tandem mass tag labeling technology reveals potential biomarkers for Parkinson's disease: a preliminary study.

Zhao Y, Zhang Y, Zhang J, Yang G

Proteomics. Clinical applications27 Nov 2021Cited by 11 (Europe PMC)

PMID34791804 (opens in a new tab)DOI10.1002/prca.202100010 (opens in a new tab)PepBankPUB-34791804
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In a plasma proteome comparison of patients with Parkinson's disease and healthy controls, TMSB4X was among the proteins implicated in PD pathogenesis.

    In plain wordsThe body's own thymosin beta‑4 in blood was linked to Parkinson's disease in a preliminary study.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    Direction not reportedPlasma TMSB4X in Parkinson's disease
    Study

    n: not reported in source

    Outcome group
    Endogenous peptide levels · Nervous system and cognition

    Source sentences

    Summary
    Several proteins, including Chitinase-3-like protein 1 (CHI3L1) and thymosin beta-4 (TMSB4X) were implicated in PD pathogenesis.
    1 context sentence
    Summary · context
    Tandem mass tag (TMT) mass spectrometry was applied using an Orbitrap Lumos mass spectrometer to analyze plasma protein expression in patients diagnosed with PD and healthy controls.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.